8 studies found for:    "Ebola virus disease"
Show Display Options
Rank Status Study
1 Completed Experimental Vaccine for Prevention of Ebola Virus Infection
Conditions: Ebola Hemorrhagic Fever;   Ebola Virus Disease;   Ebola Virus Vaccines;   Envelope Glycoprotein, Ebola Virus;   Filovirus
Intervention: Drug: VRC-EBOADV018-00-VP
2 Completed Evaluating an Ebola and a Marburg Vaccine in Uganda
Conditions: Ebola Virus Disease;   Marburg Virus Disease
Interventions: Biological: Ebola vaccine;   Biological: Marburg vaccine;   Other: Placebo injection
3 Completed Ebola and Marburg Virus Vaccines
Conditions: Ebola Vaccines;   Marburg Virus Disease;   Ebola Virus Disease;   Marburgvirus;   Ebolavirus
Interventions: Drug: VRC-EBODNA023-00-VP;   Drug: VRC-MARDNA025-00-VP
4 Withdrawn A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
Condition: Ebola Hemorrhagic Fever
Interventions: Drug: AVI-7537;   Other: Normal Saline Solution (NSS)
5 Completed Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
Condition: Ebola Hemorrhagic Fever
Interventions: Drug: Placebo;   Drug: AVI-6002
6 Suspended Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Condition: Ebola Virus Infection
Interventions: Drug: TKM-100802 for Injection;   Drug: Placebo
7 Terminated Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
Condition: Ebola Virus Infection
Interventions: Drug: TKM-100201;   Drug: Placebo
8 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Intervention: Biological: VRC-EBOADC069-00-VP

Indicates status has not been verified in more than two years